Moreover, the anti-obesity effect of OEA is also supported by its capability to control lipid metabolism by reducing serum lipid levels, hepatic lipid accumulation and adipose FAT/CD36 lipid transport in obese rodents (20–22). The gene discussed is CD36; the disease is obesity due to melanocortin 4 receptor deficiency.